Stock Track | AngioDynamics Plummets 17.23% Intraday Amid Net Loss, CEO Retirement, and Tariff Impact-To The Moon - Tiger Brokers Online Investing Community

Like
Comment
Favorite

Stock Track | AngioDynamics Plummets 17.23% Intraday Amid Net Loss, CEO Retirement, and Tariff Impact

Stock Track01-06

AngioDynamics (ANGO) saw its shares plummet by 17.23% during Tuesday's intraday trading session. The sharp decline followed the company's mixed second-quarter financial results and significant corporate updates.

The medical technology company reported a net loss of $6.4 million for the quarter, despite beating sales estimates with $79.4 million in revenue. While adjusted EPS of $0.00 surpassed expectations of a $0.09 loss, investors reacted negatively to the overall net loss and ongoing challenges.

Adding to the uncertainty, AngioDynamics announced that CEO Jim Clemmer will retire in fiscal 2027, with the board initiating a search for his successor. The company also maintained its forecast of a $4.0-$6.0 million negative impact from tariffs for fiscal 2026, offsetting some optimism from its raised full-year sales and EBITDA guidance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1117707961?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-06 23:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117707961","market":"us","top_or_hot":-1,"title":"Stock Track | AngioDynamics Plummets 17.23% Intraday Amid Net Loss, CEO Retirement, and Tariff Impact","media":"Stock Track","content":"<p>AngioDynamics (ANGO) saw its shares plummet by 17.23% during Tuesday's intraday trading session. The sharp decline followed the company's mixed second-quarter financial results and significant corporate updates.</p><p>The medical technology company reported a net loss of $6.4 million for the quarter, despite beating sales estimates with $79.4 million in revenue. While adjusted EPS of $0.00 surpassed expectations of a $0.09 loss, investors reacted negatively to the overall net loss and ongoing challenges.</p><p>Adding to the uncertainty, AngioDynamics announced that CEO Jim Clemmer will retire in fiscal 2027, with the board initiating a search for his successor. The company also maintained its forecast of a $4.0-$6.0 million negative impact from tariffs for fiscal 2026, offsetting some optimism from its raised full-year sales and EBITDA guidance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | AngioDynamics Plummets 17.23% Intraday Amid Net Loss, CEO Retirement, and Tariff Impact</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | AngioDynamics Plummets 17.23% Intraday Amid Net Loss, CEO Retirement, and Tariff Impact\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-01-06 23:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AngioDynamics (ANGO) saw its shares plummet by 17.23% during Tuesday's intraday trading session. The sharp decline followed the company's mixed second-quarter financial results and significant corporate updates.</p><p>The medical technology company reported a net loss of $6.4 million for the quarter, despite beating sales estimates with $79.4 million in revenue. While adjusted EPS of $0.00 surpassed expectations of a $0.09 loss, investors reacted negatively to the overall net loss and ongoing challenges.</p><p>Adding to the uncertainty, AngioDynamics announced that CEO Jim Clemmer will retire in fiscal 2027, with the board initiating a search for his successor. The company also maintained its forecast of a $4.0-$6.0 million negative impact from tariffs for fiscal 2026, offsetting some optimism from its raised full-year sales and EBITDA guidance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANGO","symbol_name":"Angiodynamics","start_time":0,"source_url":"","article_id":"1117707961","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117707961","pubTimestamp":1767714866,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"AngioDynamics (ANGO) saw its shares plummet by 17.23% during Tuesday's intraday trading session. The sharp decline followed the company's mixed second-quarter financial results and significant...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ANGO":"Angiodynamics"},"translate_title":"个股追踪|净亏损、CEO退休、关税影响下AngioDynamics盘中暴跌17.23%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANGO":1},"content_text":"AngioDynamics (ANGO) saw its shares plummet by 17.23% during Tuesday's intraday trading session. The sharp decline followed the company's mixed second-quarter financial results and significant corporate updates.The medical technology company reported a net loss of $6.4 million for the quarter, despite beating sales estimates with $79.4 million in revenue. While adjusted EPS of $0.00 surpassed expectations of a $0.09 loss, investors reacted negatively to the overall net loss and ongoing challenges.Adding to the uncertainty, AngioDynamics announced that CEO Jim Clemmer will retire in fiscal 2027, with the board initiating a search for his successor. The company also maintained its forecast of a $4.0-$6.0 million negative impact from tariffs for fiscal 2026, offsetting some optimism from its raised full-year sales and EBITDA guidance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}